RecruitingNCT04699292

International Prospective Registry on Local Treatment Approaches in MLS

International Prospective Registry on Local Treatment Approaches in Myxoid Liposarcomas


Sponsor

The Netherlands Cancer Institute

Enrollment

300 participants

Start Date

Jan 18, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an international registry (a structured data-collection study) for patients with myxoid liposarcoma (MLS), a type of soft tissue cancer. The goal is to collect data on local treatment approaches — like surgery and radiation — to improve understanding of best practices across different countries. **You may be eligible if...** - You are 18 or older - You have been diagnosed with myxoid liposarcoma confirmed by biopsy (including the characteristic chromosomal change t(12;16)) - Your general health status is good to moderate (ECOG 0-2) - You are willing to share coded (de-identified) information in the registry **You may NOT be eligible if...** - You have previously received radiation to the area being studied - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESurgery

Surgery

RADIATIONPreoperative RT 36Gy

Preoperative radiotherapy to 36Gy (equivalent)

RADIATIONPreoperative RT 50Gy

Preoperative radiotherapy to 50Gy (equivalent)

RADIATIONPostoperative RT 50-66Gy

Postoperative radiotherapy to 50-66Gy (equivalent)

RADIATIONRT 36Gy

Definitive radiotherapy to 36Gy (equivalent)


Locations(1)

The Netherlands Cancer Institute

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04699292


Related Trials